News
Mark Esser, PhD, was appointed the inaugural chief scientific officer and head of the upcoming Paul and Diane Manning Institute of Biotechnology at Charlottesville-based University of Virginia. In his ...
Manhasset, N.Y.-based North Shore University Hospital had the highest 30-day survival rate for coronary artery bypass graft patients among all U.S. hospitals participating in CMS’ Fiscal Year 2025 ...
Executive compensation in healthcare continues to reflect a combination of performance-based incentives, stock awards and strategic benchmarks aligned with shareholder value. In 2024, leaders at four ...
The Minnesota Bureau of Mediation Services has certified the Committee of Interns and Residents, a local of the Service Employees International Union, as the exclusive representative for more than 200 ...
M Health Fairview has opened a dedicated donor care unit to optimize outcomes for transplant patients and ease capacity strain across the region. The unit operates in partnership with LifeSource, an ...
Cardiovascular risk factors, accelerated by depression and anxiety, increase a patient’s risk for end-stage renal disease, according to a study presented at the American College of Cardiology’s 2025 ...
California has the highest hourly mean wage for physician assistants in the U.S., and Indiana has the highest hourly mean wage for PAs after adjusted for cost of living, according to data published ...
Christopher Ward, MD, has joined St. Mary’s Health Care System in Athens, Ga., as chief medical officer. Dr. Ward is an emergency medicine physician with more than 30 years of experience in healthcare ...
Susan Mooney, MD, president and CEO of Alice Peck Day Memorial Hospital in Lebanon, N.H., plans to retire. Dr. Mooney gave notice of her retirement plans earlier in April and will remain in her role ...
Ten healthcare organizations were recognized on LinkedIn’s 2025 list of the best large employers for career growth. The ninth annual ranking evaluates companies with 5,000 or more global employees on ...
Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...
At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results